Cyclo3pss

Cyclo3pss Current Liabilities

The Current Liabilities of Cyclo3pss (CYPS) as of Oct 28, 2026 is 389,147.00 USD. In the previous year, Current Liabilities was 344,937.00 USD — a change of 12.82% (higher).

Current Liabilities

389,147.00USD

YoY

12.82%

Last updated:

Current Liabilities of Cyclo3pss is 2002 389,147.00 USD. Current Liabilities of Cyclo3pss was 2001 344,937.00 USD. It decreases by 12.82% higher compared to the previous year.

The Cyclo3pss Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 1995
470,000.00 USD
Jan 1, 1996
440,000.00 USD
Jan 1, 1997
280,000.00 USD
Jan 1, 1998
820,000.00 USD
Jan 1, 1999
399,140.00 USD
Jan 1, 2000
806,955.00 USD
Jan 1, 2001
344,937.00 USD
Jan 1, 2002
389,147.00 USD
The Cyclo3pss Current Liabilities history
YEARCurrent LiabilitiesYoY
389,147.00USD+12.82%
344,937.00USD-57.25%
806,955.00USD+102.17%
399,140.00USD-51.32%
820,000.00USD+192.86%
280,000.00USD-36.36%
440,000.00USD-6.38%
470,000.00USD+291.67%
120,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyclo3pss Stock analysis

What does Cyclo3pss do? Cyclo3pss Corp licenses its proprietary technologies to partners with suitable resources and infrastructure to commercialize specific products. The company's principal technology addresses food safety, healthcare sanitizing, and laundry disinfection. Its products include Ster-O3-Zone, a medical sterilizer for the medical and pharmaceutical industries, Eco Wash, laundry equipment for hotels, nursing homes, and institutional markets, and Eco Pure, which applies ozone to sanitize turkey, beef, and pork carcasses as well as brine in cured meat products. Partners with existing infrastructure in these sectors purchase the licensing rights to deploy these technologies. Ster-O3-Zone targets medical and pharmaceutical markets, while Eco Wash serves institutional clients like hotels and nursing homes. Eco Pure focuses on meat processing applications, including carcass sanitization and brine treatment. The company generates revenue through licensing agreements, enabling partners to integrate these technologies into their existing operations without developing them in-house. The firm's licensing model allows partners to leverage Cyclo3pss Corp's proprietary technology in their respective markets. Partners include entities with resources to commercialize the technologies, such as those in healthcare, food processing, and institutional services. Cyclo3pss Corp does not sell products directly but earns income by granting licenses to these partners for specific applications. Cyclo3pss is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyclo3pss stock

Current Liabilities of Cyclo3pss is 389,147.00 USD in 2002.

Current Liabilities of Cyclo3pss changed from 344,937.00 USD to 389,147.00 USD, representing a 12.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Cyclo3pss since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Cyclo3pss historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cyclo3pss

All Key Metrics — Cyclo3pss